These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31173741)

  • 1. Tilted Disc Syndrome Associated with Serous Retinal Detachment: Long-term Prognosis. A Retrospective Multicenter Survey.
    Kubota F; Suetsugu T; Kato A; Gomi F; Takagi S; Kinoshita T; Ishikawa H; Mitamura Y; Kondo M; Iwahashi C; Kuwayama S; Kurimoto Y; Ogura Y; Yasukawa T;
    Am J Ophthalmol; 2019 Nov; 207():313-318. PubMed ID: 31173741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of macular serous neuroretinal detachment in tilted disk syndrome: report of 3 cases.
    Donati MC; Miele A; Abbruzzese G; Giuntoli M; Giansanti F; Menchini U
    Eur J Ophthalmol; 2013; 23(2):267-70. PubMed ID: 23225087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphyloma-induced Serous Maculopathy: Natural Course and Treatment Effects.
    Ravenstijn M; Martinez Ciriano JP; de Graaf GW; Klaver CCW; Yzer S
    Ophthalmol Retina; 2024 May; 8(5):499-508. PubMed ID: 38000769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
    Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Hashizume K; Mizota A; Yuzawa M
    Ophthalmology; 2015 Mar; 122(3):555-61. PubMed ID: 25444637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    Lai FH; Ng DS; Bakthavatsalam M; Chan VC; Young AL; Luk FO; Tsang CW; Brelén ME
    Am J Ophthalmol; 2016 Oct; 170():91-99. PubMed ID: 27519561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
    Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Anti-vascular Endothelial Growth Factor Treatment for Foveal Serous Retinal Detachment Associated with Inferior Staphyloma.
    Lee EK; Yu HG
    Korean J Ophthalmol; 2019 Jun; 33(3):228-237. PubMed ID: 31179654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and Anatomical Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
    Giocanti-Aurégan A; Hrarat L; Qu LM; Sarda V; Boubaya M; Levy V; Chaine G; Fajnkuchen F
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):797-800. PubMed ID: 28152140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considering photodynamic therapy as a therapeutic modality in selected cases of dome-shaped macula complicated by foveal serous retinal detachment.
    Arapi I; Neri P; Mariotti C; Gesuita R; Pirani V; Freddo F; Lutaj P; Giovannini A
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):217-23. PubMed ID: 25707047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Jain P; Anantharaman G; Gopalakrishnan M; Goyal A
    Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of different anti-vascular endothelial growth factor agents, and dexamethasone implant therapy in patients with serous retinal detachment caused by Irvine-Gass syndrome.
    Karasu B; Kesim E; Celebi ARC
    Eur J Ophthalmol; 2024 Mar; 34(2):510-523. PubMed ID: 37408434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the short-term effect of aflibercept and dexamethasone implant on serous retinal detachment in the treatment of naive diabetic macular edema.
    Bolukbasi S; Cakir A; Erden B; Karaca G
    Cutan Ocul Toxicol; 2019 Dec; 38(4):401-405. PubMed ID: 31438736
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
    Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
    Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Shiragami C; Shiraga F; Nagayama D; Iida T
    Am J Ophthalmol; 2008 Dec; 146(6):935-41.e1. PubMed ID: 18723139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study.
    Gao T; Qu J; Xiao J; Hu J; Zhao M
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1429-1439. PubMed ID: 29869216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness.
    Shi X; Wei W; Zhang C
    Chin Med J (Engl); 2014; 127(12):2279-85. PubMed ID: 24931242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy.
    van Rijssen TJ; Mohabati D; Dijkman G; Theelen T; de Jong EK; van Dijk EHC; Boon CJF
    PLoS One; 2018; 13(8):e0202549. PubMed ID: 30142176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Iida T; Kano M
    Am J Ophthalmol; 2012 Mar; 153(3):504-514.e1. PubMed ID: 22078902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.
    Bae SH; Heo J; Kim C; Kim TW; Shin JY; Lee JY; Song SJ; Park TK; Moon SW; Chung H
    Ophthalmology; 2014 Feb; 121(2):558-65. PubMed ID: 24268858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy.
    Sato T; Kishi S; Matsumoto H; Mukai R
    Am J Ophthalmol; 2010 Jun; 149(6):947-954.e1. PubMed ID: 20346441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.